U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864624) titled 'Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC' on Jan. 14. Brief Summary... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864234) titled 'Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA: a Randomise... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864819) titled 'Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UH... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864936) titled 'Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multip... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06863636) titled 'Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthriti... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06863506) titled 'Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC' on March 03. B... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864949) titled 'Efficacy of Transverse Maxillary Expansion With AMCOP Preformed Appliances' on Feb. 25. Br... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06863519) titled 'Evaluation of Endoscopic Treatment Effect Based on HVPG' on March 03. Brief Summary: This ... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06865118) titled 'Home-Based Clinical Management of Cardiac Complications in Systemic Sclerosis' on Feb. 17. ... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06863818) titled 'Overcoming Resistance to EGFR Neutralization by Combination of Monoclonal Antibodies and No... Read More